WO2021078150A1
|
|
Pentacyclic triterpene tgr5 receptor agonist and preparation method therefor and uses thereof
|
WO2021063366A1
|
|
Drug for treating artery-related diseases, and use thereof
|
WO2021052501A1
|
|
Heterocyclic amide compound, pharmaceutically acceptable salt thereof, and preparation method therefor and use thereof
|
WO2021047677A1
|
|
Irak4 kinase inhibitor and preparation thereof and use thereof
|
WO2021047464A1
|
|
Use of 4-[9-(6-aminopurinyl)]-2(s)-hydroxymethyl butyrate for preparing ophthalmic preparations
|
WO2021043217A1
|
|
Compound having axl and c-met kinase inhibitory activity, preparation thereof and application thereof
|
WO2021037188A1
|
|
Pharmaceutical use of pyrimido[5,4-b]pyrrolizine compound
|
WO2021037244A1
|
|
Pharmaceutical composition and application thereof
|
WO2021037160A1
|
|
Tumor enzyme-responsive recombinant pyroptosis protein delivery system and antitumor use thereof
|
WO2021036937A1
|
|
Application of pde3 inhibitor and cytokine in treatment of tumor
|
CN111728953A
|
|
Sustained-release preparation of tofacitinib or salt thereof and preparation method thereof
|
CN112239459A
|
|
Fused ring pyrimidine amino compound, preparation method thereof, pharmaceutical composition and application
|
CN111920541A
|
|
Method for constructing sepsis compound animal model
|
WO2020259612A1
|
|
Antidepressant steroid compound
|
WO2020259539A1
|
|
4-pyridine substituted phthalazinone compound and preparation method, pharmaceutical composition, and use thereof
|
CN112094266A
|
|
Pyrrolopyridinone compound, preparation method, composition and application thereof
|
CN111892648A
|
|
Novel coronavirus polypeptide vaccine coupled with TLR7 agonist and application thereof
|
WO2020244518A1
|
|
Compound with benzyloxy aromatic ring structure, preparation method and use thereof
|
CN112010859A
|
|
Fused ring compound, preparation method and application thereof
|
CN111574441A
|
|
Eutectic of nicorandil and salicylic acid as well as preparation method and application of eutectic
|